Literature DB >> 14438706

Recurrent staphylococcal infections and the duration of the carrier state.

L ROODYN.   

Abstract

Entities:  

Keywords:  STAPHYLOCOCCAL INFECTIONS/transmission

Mesh：

Year:  1960        PMID： 14438706      PMCID： PMC2134315          DOI： 10.1017/s0022172400038092

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


× No keyword cloud information.
  5 in total

1.  Further studies on the transmission of Staph. aureus.

Authors:  R HARE; M RIDLEY
Journal:  Br Med J       Date:  1958-01-11

2.  Staphylococcal infections in general practice.

Authors:  L ROODYN
Journal:  Br Med J       Date:  1954-12-04

3.  Morbidity statistics from general practice.

Authors:  W P LOGAN
Journal:  Practitioner       Date:  1954-08

4.  Bacteriophage typing of strains of staphylococci isolated in Australia.

Authors:  P M ROUNTREE
Journal:  Lancet       Date:  1953-03-14       Impact factor: 79.321

5.  The effect of nutritional disturbances on the susceptibility of mice to staphylococcal infections.

Authors:  J M SMITH; R J DUBOS
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307
  5 in total
  4 in total

Review 1.  Antibiotic resistance plasmids of Staphylococcus aureus and their clinical importance.

Authors:  R W Lacey
Journal:  Bacteriol Rev       Date:  1975-03

2.  Healthy carriage of Staphylococcus aureus: its prevalence and importance.

Authors:  R E WILLIAMS
Journal:  Bacteriol Rev       Date:  1963-03

3.  Variation and persistence of methicillin-resistant Staphylococcus aureus strains among individual patients over extended periods of time.

Authors:  J N Maslow; S Brecher; J Gunn; A Durbin; M A Barlow; R D Arbeit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

4.  Staphylococcal superantigens stimulate immortalized human adipocytes to produce chemokines.

Authors:  Bao G Vu; Francoise A Gourronc; David A Bernlohr; Patrick M Schlievert; Aloysius J Klingelhutz
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.